ValueScreener

ValueScreener company report

Diversified Healthcare Trust (DHC)

NASDAQ / Real Estate / REIT - Healthcare Facilities

Share price

7.61 USD Market dataClose of Oct 15, 2026

Market capitalisation

1.84B USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2025, filed Feb 24, 2026
Ratios computed
Oct 15, 2026
Filed years
18, FY2008 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on equity

-17.2% Computed

From the FY2025 filing

Read quality

Financial strength

Debt to equity

n/a Computed

From the FY2025 filing

Why n/a

The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.

Read financial strength

Valuation

Price to book

1.10x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

-9.1% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, as filed

FY2016 Revenue: 1.06B USDFY2016 Net income: 141.3M USDFY2017 Revenue: 1.07B USDFY2017 Net income: 147.6M USDFY2018 Revenue: 1.12B USDFY2018 Net income: 286.9M USDFY2019 Revenue: 1.04B USDFY2019 Net income: -88.2M USDFY2020 Revenue: 1.63B USDFY2020 Net income: -139.5M USDFY2021 Revenue: 1.38B USDFY2021 Net income: 174.5M USDFY2022 Revenue: 1.28B USDFY2022 Net income: -15.8M USDFY2023 Revenue: 1.41B USDFY2023 Net income: -293.6M USDFY2024 Revenue: 1.50B USDFY2024 Net income: -370.3M USDFY2025 Revenue: 1.54B USDFY2025 Net income: -285.9M USD
Revenue Net income10 filed fiscal years, from the annual reports; the table in Filings names each document.
Named tests met
1 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it good

Return on equity was -17.2% in FY2025, in the band labelled "Likely below the cost of equity" (below 8.0%), on lines anchored on Damodaran's cost-of-capital data, suggesting returns on shareholders' money below the usual cost of equity.

Today, against the Real Estate sector (221 companies), -17.2% sits at the 14th percentile; the middle half of that group runs from -4.0% to 9.5%.

Year by year against peers
Whether Diversified Healthcare Trust's return on equity stayed above the median of the Real Estate sector, year by year. (FY2022 to FY2025, 4 fiscal years of Diversified Healthcare Trust with a comparable figure)
The direction
Which way Diversified Healthcare Trust's return on equity has moved, and how steadily. (FY2016 to FY2025, 10 filed years of Diversified Healthcare Trust)
What to check next
What to check next on Diversified Healthcare Trust, and where in its filings. (1 question for Diversified Healthcare Trust)
In one paragraph
One paragraph on Diversified Healthcare Trust's returns, cash, balance sheet and price. (5 of sixteen figures read for Diversified Healthcare Trust)

These are DHC’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research DHCPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 24, 2026, accession 0001075415-26-000013.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Diversified Healthcare Trust: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax
Why n/a

The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.

n/a ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Return on equity-17.2% ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Return on capital employed, pre-tax
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Return on assets-6.6% ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Gross margin
Why n/m

This filer reports no gross profit line, so there is no gross margin to compute. Banks, insurers and REITs do not present cost of revenue.

n/m ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Operating margin
Why n/a

No operating income line is filed for this year.

n/a ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Net margin-18.6% ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
DHC -18.6%
AHRT 2.7%UHT 17.8%CHCT 4.2%
-18.6%17.8%
Net margin: DHC against the 3 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Diversified Healthcare Trust: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity
Why n/a

The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.

n/a ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Current ratio
Why n/m

A property trust presents an unclassified balance sheet: buildings are long-lived assets and mortgage debt is drawn against them, so there is no split between current and non-current for a current ratio to divide. Look at net debt to EBITDA and interest coverage instead.

n/m ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Quick ratio
Why n/m

A property trust presents an unclassified balance sheet: buildings are long-lived assets and mortgage debt is drawn against them, so there is no split between current and non-current for a current ratio to divide. Look at net debt to EBITDA and interest coverage instead.

n/m ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Interest coverage
Why n/a

No operating income line is filed for this year.

n/a ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Altman Z-score
Why n/m

Altman's Z-Score rewards working capital and asset turnover, neither of which a property trust has. It reads distress for healthy REITs by construction, so we do not show it.

n/m ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Net debt
Why n/a

The FY2025 balance sheet carries no net debt we could read.

n/a ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Total assets 4.36BTotal liabilities 2.70BShareholders' equity 1.67BOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What Diversified Healthcare Trust owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 24, 2026, 0001075415-26-000013).

Diversified Healthcare Trust: balance sheet position
Total assets4.36B FiledFY2025 10-K, filed Feb 24, 2026
Total liabilities2.70B FiledFY2025 10-K, filed Feb 24, 2026
Shareholders' equity1.67B FiledFY2025 10-K, filed Feb 24, 2026
Cash105.4M FiledFY2025 10-K, filed Feb 24, 2026
Total debtn/a FiledFY2025 10-K, filed Feb 24, 2026
Net debtn/a
Current ration/m
Debt to equityn/a
  • Debt to equity: FY2025: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
  • Current ratio: FY2025: A property trust presents an unclassified balance sheet: buildings are long-lived assets and mortgage debt is drawn against them, so there is no split between current and non-current for a current ratio to divide. Look at net debt to EBITDA and interest coverage instead.
  • Interest cover: FY2025: No operating income line is filed for this year.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Diversified Healthcare Trust: what the market charges, each with its source
FigureValue, source and document
Price to earnings
Why n/m

GAAP earnings for a property trust are charged with depreciation on buildings that are generally appreciating, so a P/E built on them overstates how expensive the trust is. Use price to FFO.

n/m ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
P/E on trailing twelve months0.56x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book1.10x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Price to sales1.19x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Enterprise value to EBIT
Why n/a

The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Enterprise value to EBITDA
Why n/a

The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Price to earnings over growth
Why n/m

GAAP earnings for a property trust are charged with depreciation on buildings that are generally appreciating, so a P/E built on them overstates how expensive the trust is. Use price to FFO.

n/m ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Diluted earnings per share-1.19 USD FiledFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Graham number
Why n/m

Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.

n/m ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013

We publish no fair value or price target of our own. Value DHC on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Diversified Healthcare Trust today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Diversified Healthcare Trust: valuation
Share price7.61 USD
Market capitalisation1.84B USD
Enterprise value to EBITDAn/a
Graham numbern/m
Diluted earnings per share, FY2025-1.19 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Oct 3, 2016: low 0.36x, median 12.24x, high 45.42x, latest 0.56x. 970 trading days with a meaningful ratio, 1,551 more on a loss and left out. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like Diversified Healthcare Trust

  1. Armada Hoffler Properties, Inc. (AHRT)Market cap 572.6M USD
  2. Universal Health Realty Income Trust (UHT)Market cap 530.8M USD
  3. Community Healthcare Trust Incorporated (CHCT)Market cap 379.9M USD

Same industry (REIT - Healthcare Facilities) and size band (Small, 300M to 2B), nearest in market value and net margin. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Diversified Healthcare Trust: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield-9.1% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Free cash flow-166.4M USD ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Free cash flow margin-10.8% ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Dividend yield0.5% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Payout ratio
Why n/m

A REIT pays out of funds from operations, not GAAP earnings. A payout ratio on earnings reads far above 100% for a perfectly safe distribution. Use the FFO payout ratio.

n/m ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
FY2016 Free cash flow: 324.8M USDFY2016 Net income: 141.3M USDFY2017 Free cash flow: 302.1M USDFY2017 Net income: 147.6M USDFY2018 Free cash flow: 289.0M USDFY2018 Net income: 286.9M USDFY2019 Free cash flow: 43.4M USDFY2019 Net income: -88.2M USDFY2020 Free cash flow: -27.0M USDFY2020 Net income: -139.5M USDFY2021 Free cash flow: -290.9M USDFY2021 Net income: 174.5M USDFY2022 Free cash flow: -339.7M USDFY2022 Net income: -15.8M USDFY2023 Free cash flow: -224.5M USDFY2023 Net income: -293.6M USDFY2024 Free cash flow: -89.5M USDFY2024 Net income: -370.3M USDFY2025 Free cash flow: -166.4M USDFY2025 Net income: -285.9M USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Diversified Healthcare Trust: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
n/mFY2025Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
1.10xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
-9.1%FY2025Oct 15, 2026
n/aFY2025Feb 24, 2026
n/a The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
0.5%FY2025Oct 15, 2026
n/aFY2025Feb 24, 2026
n/a The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
n/mFY2025Feb 24, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
1.19xFY2025Oct 15, 2026
n/mFY2025Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/mFY2025Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/mFY2025Feb 24, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/mFY2025Feb 24, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 18 filed fiscal years on record, FY2008 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

10 filed fiscal years, FY2016 to FY2025, read from the annual reports Diversified Healthcare Trust filed with the SEC. Each year names its filing. Amounts in USD, as filed.

Diversified Healthcare Trust: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY20251.54B-116.4M-285.9M-1.19-166.4Mn/a-17.2%10-K, Feb 24, 20260001075415-26-000013
FY20241.50B-136.1M-370.3M-1.55-89.5Mn/a-18.9%10-K, Feb 25, 20250001075415-25-000012
FY20231.41B-80.9M-293.6M-1.23-224.5Mn/a-12.6%10-K, Feb 26, 20240001075415-24-000007
FY20221.28B188.3M-15.8M-0.07-339.7Mn/a-0.6%10-K, Mar 1, 20230001075415-23-000008
FY20211.38B437.1M174.5M0.73-290.9Mn/a6.5%10-K, Feb 24, 20220001075415-22-000007
FY20201.63B68.4M-139.5M-0.59-27.0Mn/a-5.6%10-K, Feb 25, 20210001075415-21-000005
FY20191.04B97.3M-88.2M-0.3743.4Mn/a-3.2%10-K, Mar 2, 20200001075415-20-000009
FY20181.12B471.7M286.9M1.21289.0Mn/a9.5%10-K, Mar 1, 20190001075415-19-000013
FY20171.07B275.2M147.6M0.62302.1M25.6%4.8%10-K, Feb 27, 20180001075415-18-000010
FY20161.06B303.1M141.3M0.60324.8M28.6%4.4%10-K, Feb 27, 20170001075415-17-000007
  • Revenue, compound annual growth FY2016 to FY2025: 4.2%
  • Earnings: Earnings was not positive in both 2016 and 2025, so a compound rate across the window is not defined. Both figures are in the table.
  • Earnings per share: Earnings per share was not positive in both 2016 and 2025, so a compound rate across the window is not defined. Both figures are in the table.
  • Free cash flow: Free cash flow was not positive in both 2016 and 2025, so a compound rate across the window is not defined. Both figures are in the table.

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Diversified Healthcare Trust: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score
Why n/m

The Beneish M-Score is built on gross margin, receivables and asset quality indices estimated on non-financial firms. Those inputs are not defined here.

n/m ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Piotroski F-score
Why n/m

2 of the nine Piotroski signals are undefined for an equity REIT: signal 6 (rising current ratio), signal 8 (rising gross margin). We do not publish a partial score under the full score's name.

n/m ComputedFY2025 10-K, filed Feb 24, 2026, 0001075415-26-000013
Named tests met1 of 30 Computed
Beta-0.02 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 1 met, 18 not met, 11 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
Low P/S, rising earnings (James O'Shaughnessy)
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; High F-score, low P/B (Joseph Piotroski); High returns and growth; Gross margin, turnover (Robert Novy-Marx); High yield, low payout; Dividends and buybacks; Low beta, profitable; Near the 52-week low; High returns, low debt; Owner earnings yield; High return on tangibles; Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured
Earnings yield and ROIC (Joel Greenblatt); Three forensic scores; Low PEG, low debt (Peter Lynch); EV/EBITDA and coverage; ROIC at or above WACC; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); Cash-covered dividend; Clean books, high ROIC; Cheapest quarter on P/E (David Dreman). A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(18)
  • Current Ratio: A property trust presents an unclassified balance sheet: buildings are long-lived assets and mortgage debt is drawn against them, so there is no split between current and non-current for a current ratio to divide. Look at net debt to EBITDA and interest coverage instead.
  • Debt to Equity: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
  • Piotroski F-Score: 2 of the nine Piotroski signals are undefined for an equity REIT: signal 6 (rising current ratio), signal 8 (rising gross margin). We do not publish a partial score under the full score's name.
  • P/E Ratio: GAAP earnings for a property trust are charged with depreciation on buildings that are generally appreciating, so a P/E built on them overstates how expensive the trust is. Use price to FFO.
  • EV/EBIT: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
  • Return on Invested Capital: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
  • Altman Z-Score: Altman's Z-Score rewards working capital and asset turnover, neither of which a property trust has. It reads distress for healthy REITs by construction, so we do not show it.
  • Beneish M-Score: The Beneish M-Score is built on gross margin, receivables and asset quality indices estimated on non-financial firms. Those inputs are not defined here.
  • PEG Ratio: GAAP earnings for a property trust are charged with depreciation on buildings that are generally appreciating, so a P/E built on them overstates how expensive the trust is. Use price to FFO.
  • Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Gross Margin: This filer reports no gross profit line, so there is no gross margin to compute. Banks, insurers and REITs do not present cost of revenue.
  • EV/EBITDA: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
  • Interest Coverage: No operating income line is filed for this year.
  • Payout Ratio: A REIT pays out of funds from operations, not GAAP earnings. A payout ratio on earnings reads far above 100% for a perfectly safe distribution. Use the FFO payout ratio.
  • ROIC-WACC Spread: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
  • Price To Ncav: Net current asset value needs current assets, which an unclassified balance sheet does not report.
  • Price To Graham: Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.
  • Dividend Coverage Ratio: Distribution coverage for a REIT is measured against funds from operations, not against free cash flow computed after acquisition capital expenditure.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 18 figures could not be read on this company, among them Current Ratio, Debt to Equity, Piotroski F-Score. Each blank in the table above names the rest, with its reason. 11 named tests come back incomplete because of them, which is neither met nor missed.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map
  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.